Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
1.430
-0.030 (-2.05%)
Apr 25, 2025, 11:43 AM EDT - Market open
Tango Therapeutics Employees
Tango Therapeutics had 155 employees as of December 31, 2024. The number of employees increased by 15 or 10.71% compared to the previous year.
Employees
155
Change (1Y)
15
Growth (1Y)
10.71%
Revenue / Employee
$271,413
Profits / Employee
-$840,658
Market Cap
154.59M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 155 | 15 | 10.71% |
| Dec 31, 2023 | 140 | 30 | 27.27% |
| Dec 31, 2022 | 110 | 19 | 20.88% |
| Dec 31, 2021 | 91 | 14 | 18.18% |
| Dec 31, 2020 | 77 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TNGX News
- 4 weeks ago - Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline with Five Posters at the American Association for Cancer Research (AACR) Annual Meeting 2025 - GlobeNewsWire
- 2 months ago - Tango Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Highlights - GlobeNewsWire
- 3 months ago - Tango Therapeutics to Present at the Guggenheim SMID Cap Biotechnology Conference - GlobeNewsWire
- 3 months ago - Tango Therapeutics: Chance For A Short Squeeze - Seeking Alpha
- 5 months ago - Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 5 months ago - Tango Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference - Business Wire
- 6 months ago - Tango Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights - Business Wire
- 6 months ago - Tango Therapeutics Reports Positive TNG462 Clinical Data and Provides Update on PRMT5 Development Program - Business Wire